The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Vasodilation

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Vasodilation

 

Psychiatry related information on Vasodilation

 

High impact information on Vasodilation

 

Chemical compound and disease context of Vasodilation

 

Biological context of Vasodilation

 

Anatomical context of Vasodilation

 

Associations of Vasodilation with chemical compounds

  • The integrity of these fibers was assessed objectively by measuring axon reflex vasodilation in response to stimulation with 10 percent acetylcholine introduced by electrophoresis [29].
  • It rose during brief vasodilation and fell during stimulation of nonexocytotic catecholamine release by tyramine and during ganglionic blockade [30].
  • The ability of long-term alpha-receptor blockade and vasodilation with trimazosin (TMZ) to improve exercise capacity was studied in patients with chronic, stable heart failure of varying severity (functional exercise classes B to D) [31].
  • We describe a significant correlation between NGF depletion and decreased skin axon-reflex vasodilation, mediated by small sensory fibers partly via substance P release [32].
  • Role of prostaglandin-mediated vasodilatation in inflammation [33].
 

Gene context of Vasodilation

 

Analytical, diagnostic and therapeutic context of Vasodilation

References

  1. Attenuation of isoproterenol-mediated vasodilatation in blacks. Lang, C.C., Stein, C.M., Brown, R.M., Deegan, R., Nelson, R., He, H.B., Wood, M., Wood, A.J. N. Engl. J. Med. (1995) [Pubmed]
  2. The effect of atherosclerosis on the vasomotor response of coronary arteries to mental stress. Yeung, A.C., Vekshtein, V.I., Krantz, D.S., Vita, J.A., Ryan, T.J., Ganz, P., Selwyn, A.P. N. Engl. J. Med. (1991) [Pubmed]
  3. The effects of vasodilation with prostacyclin on oxygen delivery and uptake in critically ill patients. Bihari, D., Smithies, M., Gimson, A., Tinker, J. N. Engl. J. Med. (1987) [Pubmed]
  4. Improvement in exercise performance by inhalation of methoxamine in patients with impaired left ventricular function. Cabanes, L., Costes, F., Weber, S., Regnard, J., Benvenuti, C., Castaigne, A., Guerin, F., Lockhart, A. N. Engl. J. Med. (1992) [Pubmed]
  5. The clinical pharmacology of L-arginine. Böger, R.H., Bode-Böger, S.M. Annu. Rev. Pharmacol. Toxicol. (2001) [Pubmed]
  6. Weight loss in combination with physical activity improves endothelial dysfunction in human obesity. Sciacqua, A., Candigliota, M., Ceravolo, R., Scozzafava, A., Sinopoli, F., Corsonello, A., Sesti, G., Perticone, F. Diabetes Care (2003) [Pubmed]
  7. Methyl nicotinate-induced vasodilation in generalized social phobia. Katzman, M., Cornacchi, S., Coonerty-Femiano, A., Hughes, B., Vermani, M., Struzik, L., Ross, B.M. Neuropsychopharmacology (2003) [Pubmed]
  8. Tetrahydrobiopterin, a cofactor for NOS, improves endothelial dysfunction during chronic alcohol consumption. Sun, H., Patel, K.P., Mayhan, W.G. Am. J. Physiol. Heart Circ. Physiol. (2001) [Pubmed]
  9. Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction. Aversa, A., Isidori, A.M., Spera, G., Lenzi, A., Fabbri, A. Clin. Endocrinol. (Oxf) (2003) [Pubmed]
  10. Atrial natriuretic peptide in brain and pituitary gland. Gutkowska, J., Antunes-Rodrigues, J., McCann, S.M. Physiol. Rev. (1997) [Pubmed]
  11. The effect of the ingestion of ethanol on obstruction of the left ventricular outflow tract in hypertrophic cardiomyopathy. Paz, R., Jortner, R., Tunick, P.A., Sclarovsky, S., Eilat, B., Perez, J.L., Kronzon, I. N. Engl. J. Med. (1996) [Pubmed]
  12. Attenuation of isoproterenol-mediated vasodilatation in blacks. Goldsmith, S.R. N. Engl. J. Med. (1995) [Pubmed]
  13. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. Anderson, T.J., Meredith, I.T., Yeung, A.C., Frei, B., Selwyn, A.P., Ganz, P. N. Engl. J. Med. (1995) [Pubmed]
  14. Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. Panza, J.A., Epstein, S.E., Quyyumi, A.A. N. Engl. J. Med. (1991) [Pubmed]
  15. Role of K+ ATP channels and adenosine in the regulation of coronary blood flow during exercise with normal and restricted coronary blood flow. Duncker, D.J., van Zon, N.S., Ishibashi, Y., Bache, R.J. J. Clin. Invest. (1996) [Pubmed]
  16. Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. Stein, C.M., Nelson, R., Deegan, R., He, H., Wood, M., Wood, A.J. J. Clin. Invest. (1995) [Pubmed]
  17. Cultured human synovial fibroblasts rapidly metabolize kinins and neuropeptides. Bathon, J.M., Proud, D., Mizutani, S., Ward, P.E. J. Clin. Invest. (1992) [Pubmed]
  18. ATP-dependent K+ channels modulate vasoconstrictor responses to severe hypoxia in isolated ferret lungs. Wiener, C.M., Dunn, A., Sylvester, J.T. J. Clin. Invest. (1991) [Pubmed]
  19. Insulin resistance and vasodilation in essential hypertension. Studies with adenosine. Natali, A., Bonadonna, R., Santoro, D., Galvan, A.Q., Baldi, S., Frascerra, S., Palombo, C., Ghione, S., Ferrannini, E. J. Clin. Invest. (1994) [Pubmed]
  20. Vasopressin-stimulated release of atriopeptin: endocrine antagonists in fluid homeostasis. Manning, P.T., Schwartz, D., Katsube, N.C., Holmberg, S.W., Needleman, P. Science (1985) [Pubmed]
  21. ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease. Böger, R.H., Zoccali, C. Atherosclerosis. Supplements. (2003) [Pubmed]
  22. Hypoxia-reoxygenation triggers coronary vasospasm in isolated bovine coronary arteries via tyrosine nitration of prostacyclin synthase. Zou, M.H., Bachschmid, M. J. Exp. Med. (1999) [Pubmed]
  23. Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis. Quyyumi, A.A., Dakak, N., Andrews, N.P., Husain, S., Arora, S., Gilligan, D.M., Panza, J.A., Cannon, R.O. J. Clin. Invest. (1995) [Pubmed]
  24. Atrial natriuretic peptide: an essential physiological regulator of transvascular fluid, protein transport, and plasma volume. Curry, F.R. J. Clin. Invest. (2005) [Pubmed]
  25. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Miki, T., Suzuki, M., Shibasaki, T., Uemura, H., Sato, T., Yamaguchi, K., Koseki, H., Iwanaga, T., Nakaya, H., Seino, S. Nat. Med. (2002) [Pubmed]
  26. Amplification of calcium-induced gene transcription by nitric oxide in neuronal cells. Peunova, N., Enikolopov, G. Nature (1993) [Pubmed]
  27. Coronary vascular reactivity after acute myocardial ischemia. Ku, D.D. Science (1982) [Pubmed]
  28. Tumor necrosis factor alpha activates soluble guanylate cyclase in bovine glomerular mesangial cells via an L-arginine-dependent mechanism. Marsden, P.A., Ballermann, B.J. J. Exp. Med. (1990) [Pubmed]
  29. Impaired neurogenic vascular response in patients with diabetes and neuropathic foot lesions. Parkhouse, N., Le Quesne, P.M. N. Engl. J. Med. (1988) [Pubmed]
  30. Radioimmunoassay of chromogranin A in plasma as a measure of exocytotic sympathoadrenal activity in normal subjects and patients with pheochromocytoma. O'Connor, D.T., Bernstein, K.N. N. Engl. J. Med. (1984) [Pubmed]
  31. Long-term vasodilator therapy with trimazosin in chronic cardiac failure. Weber, K.T., Kinasewitz, G.T., West, J.S., Janicki, J.S., Reichek, N., Fishman, A.P. N. Engl. J. Med. (1980) [Pubmed]
  32. The role of endogenous nerve growth factor in human diabetic neuropathy. Anand, P., Terenghi, G., Warner, G., Kopelman, P., Williams-Chestnut, R.E., Sinicropi, D.V. Nat. Med. (1996) [Pubmed]
  33. Role of prostaglandin-mediated vasodilatation in inflammation. Williams, T.J., Peck, M.J. Nature (1977) [Pubmed]
  34. Endothelin and calcium antagonists in the skin microcirculation of patients with coronary artery disease. Wenzel, R.R., Duthiers, N., Noll, G., Bucher, J., Kaufmann, U., Lüscher, T.F. Circulation (1996) [Pubmed]
  35. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure. Relation to nitric oxide-dependent vasodilation in the forearm circulation. Katz, S.D., Rao, R., Berman, J.W., Schwarz, M., Demopoulos, L., Bijou, R., LeJemtel, T.H. Circulation (1994) [Pubmed]
  36. Characterization of the endokinins: human tachykinins with cardiovascular activity. Page, N.M., Bell, N.J., Gardiner, S.M., Manyonda, I.T., Brayley, K.J., Strange, P.G., Lowry, P.J. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  37. Endothelin ETA and ETB receptors cause vasoconstriction of human resistance and capacitance vessels in vivo. Haynes, W.G., Strachan, F.E., Webb, D.J. Circulation (1995) [Pubmed]
  38. LPS inhibits endothelin-1-induced endothelial NOS activation in hepatic sinusoidal cells through a negative feedback involving caveolin-1. Kamoun, W.S., Karaa, A., Kresge, N., Merkel, S.M., Korneszczuk, K., Clemens, M.G. Hepatology (2006) [Pubmed]
  39. Disparate effects of insulin on isolated rabbit afferent and efferent arterioles. Juncos, L.A., Ito, S. J. Clin. Invest. (1993) [Pubmed]
  40. Regulation of blood flow in Paget's disease of bone. Heistad, D.D., Abboud, F.M., Schmid, P.G., Mark, A.L., Wilson, W.R. J. Clin. Invest. (1975) [Pubmed]
  41. Role of inducible nitric oxide synthase in regulation of pulmonary vascular tone in the late gestation ovine fetus. Rairigh, R.L., Le Cras, T.D., Ivy, D.D., Kinsella, J.P., Richter, G., Horan, M.P., Fan, I.D., Abman, S.H. J. Clin. Invest. (1998) [Pubmed]
  42. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. Supajatura, V., Ushio, H., Nakao, A., Akira, S., Okumura, K., Ra, C., Ogawa, H. J. Clin. Invest. (2002) [Pubmed]
  43. Angiotensin and thromboxane in the enhanced renal adrenergic nerve sensitivity of acute renal failure. Robinette, J.B., Conger, J.D. J. Clin. Invest. (1990) [Pubmed]
 
WikiGenes - Universities